A young zebra finch learning to sing may not sound like much at first, just a babbling stream of chirps and whistles. But ...
Seemingly overnight, TikTok and Instagram were inundated with posts celebrating the niche world of maritime sea shanties. The ...
With a small blue crane, four researchers hoist a cylindrical fuel cell, which looks like a stack of flattened silver and ...
Researchers at MIT have suggested that rice seeds can hear the sound of rain, according to a new study. MIT calls it "the ...
When it comes to conversation, the closest the animal kingdom gets to human-like abilities may be found in an unassuming ...
Cells use a surprising “pearling” motion to evenly distribute mitochondrial DNA. This newly uncovered process may be key to ...
In a study published in Cell Reports, biomedical scientist Xuecai Ge at the University of California, Riverside and her team ...
What was the last time you noticed goosebumps on your skin? Goosebumps are a universal human experience, whether triggered by ...
UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...
UCB will pay up to $2.2bn for Candid Therapeutics, betting on cizutamig and the wider T-cell engager rush in autoimmune disease.
UCB, a global biopharmaceutical company, today announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage biotechnology ...